4th Quarter - Report

GREATER NEW YORK HOSPITAL ASSOCIATION for GREATER NEW YORK HOSPITAL ASSOCIATION

Firm
Client
Income
—
Expenses
$290,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare and Medicaid disproportionate share hospital cuts, including DSH Reduction Relief Act - support amendments to mitigate the impact of cuts on losing hospitals, postpone Medicaid DSH cuts; Graduate Medical Education issues (including Resident Physician Shortage Reduction Act (S.577/H.R.1180) - support; Amendments to the Medicare hospital readmissions penalty program methodology (providing SES adjustments, fixing the formula flaw), H.R.4188/S.2501 - support; IMPACT Act (S.2553/H.R.4994), support reducing burdensome hospital requirements in original bill; support of final bill; Medicare Audit Improvement Act (H.R.1250/S.1012) and other issues related Medicare claims appeal backlogs - support; Proposals to amend the 2 Midnight Policy (CMS-1599-F)(H.R. 3698/S.2082) - support; comments on House Ways and Means discussion draft legislation, Hospital Improvements for Payment Act of 2014, concerns about new proposed short stay payment methdology and impact on teaching hospitals; CMS Disallowance to NYS File No.:NY-2014-03-MAP - oppose, support NYS Congressional delegation letter to CMS; legislation to create a comprehensive Medicare home infusion benefit (H.R.5435) - support; comments on physician services pertaining to non-face-to-face chronic care management services (CMS-1612-P); support NYS Congressional delegation letter to CMS on NYS State plan amendments on Medicaid rates for hospitals (2% cut restoration, Vital Access Provider funds).

Contacted: SENATE; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); White House Office; HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Housing & Urban Development, Dept of (HUD)

Bills named: H.R. 5435 (113th), H.R. 4994 (113th), H.R. 1180 (113th), S. 577 (113th), H.R. 3698 (113th), S. 2553 (113th), H.R. 1250 (113th), S. 1012 (113th), S. 2082 (113th), S. 2501 (113th), H.R. 4188 (113th)

Pharmacy PHA

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including implementation of the Drug Quality and Security Act (P.L.113-54) and P.L.112-144; support medical device pricing transparency and prohibition on medical device price "gag clauses"; preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; opposing the current HRSA guidance on the 340b drug pricing GPO exclusion (HRSA Release 2013-1); opposing taxes on mobile health applications (FDA mobile health guidance and regulatory risk-based framework, FDA-2011-D-0530, FDA-2014-N-0339); comments on regulations affecting point-of-use care for glucose monitoring systems (FDA-2013-D-1445); educating policymakers on hospital drug shortages and significant drug price increases; pharmaceutical labeling of generic drugs (FDA-2013-N-0500); legislation to create a comprehensive Medicare home infusion benefit (H.R.5435) - support; comments on Medicare physician services pertaining to non-face-to-face chronic care management services (CMS-1612-P); reforming the durable medical equipment competitive bidding program; and hospice medication coverage reforms.

LobbyistCovered position, as disclosed
JONATHAN COOPER —
LEE H PERLMAN —
KENNETH E RASKE —
DAVID C RICH —
AISLING WARDE ZACCARELLI —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); SENATE; White House Office; Housing & Urban Development, Dept of (HUD)

Bills named: H.R. 5435 (113th)

Health Issues HCR

Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system, advocated in support of House and Senate letters in support; H.R.83, Consolidated and Further Continuing Appropriations Act of 2015, support Ebola funding for hospital preparedness and treatment activities; sepsis (ensuring that if new Federal rules are put into place they are not inconsistent with what NY hospitals are required to do under NYS law); Flexibility in Health IT Reporting Act of 2014 (H.R.5481) - support; educating members of Congress about hospital price transparency issues; Affordable Care Act - support for coverage expansions and delivery system reforms; veterans health care, support for prompt payment provisions (H.R.3230/H.R.4810)

Contacted: Health Resources & Services Administration (HRSA); White House Office; Housing & Urban Development, Dept of (HUD); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 4810 (113th), H.R. 5481 (113th), H.R. 83 (113th), H.R. 3230 (113th)

Housing HOU

Support and protect the FHA hospital and nursing home mortgage insurance programs.

LobbyistCovered position, as disclosed
JONATHAN COOPER —
KENNETH E RASKE —
DAVID C RICH —
SUSAN C WALTMAN —
ELISABETH R WYNN —

Contacted: Housing & Urban Development, Dept of (HUD); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); White House Office

Insurance INS

Support Senate proposal for re-authorization of the Terrorism Risk Insurance Act (S.2244).

LobbyistCovered position, as disclosed
JONATHAN COOPER —
KENNETH E RASKE —
DAVID C RICH —

Contacted: Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Housing & Urban Development, Dept of (HUD); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC)

Bills named: S. 2244 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.